Acetylcysteine for st elevation myocardial infarction

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 Jun 2013: Trial registered, NCT01878344

The trials

NCT01878344: Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention

State
Under way
Phase
Phase 3
People
100 taking part
Started
Jan 2013
Primary completion
Jan 2018
Arms
n-acetyl cysteine
Results
None posted
  1. 14 Jun 2013: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Also known as Acetadote, Broncholysin, Cetylev, Fluimicil, Fluimucetin, Mercapturic acid, Mucomyst, Mucosil, N-Acetyl cysteine, Oristar nalc, Respaire, Syntemucol, Tixair.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.